Antihypertensive therapy: why and in whom
Thursday 22nd May 2025 / 12:00 - 12:30pm / Online via Zoom
Join us for the upcoming – DaRe2THINK Webinar:
This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.
This talk will summarise the latest evidence on the importance of blood pressure lowering. It will address some of the less-well known effects of antihypertensive therapy on various health outcomes and contrast them with LDL-lowering therapy.
Speaker: Dr Kazem Rahimi FRCP DM MSc FESC
Kazem Rahimi is a Professor of Cardiovascular Medicine and Population Health, at the University of Oxford and a consultant cardiologist at the Oxford University Hospitals NHS Trust. Kazem leads the Deep Medicine programme at the Nuffield Department of Women’s and Reproductive Health with a major interest in application of machine learning approaches to electronic health records. He also leads the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC), which is an international collaboration of all the major trials of blood pressure lowering drugs.
DaRe2THINK
This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.
DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.
Webinar schedule:
12:00 – 12:15 – Presentation by Dr Kazem Rahimi
12:15 – 12:25 – Q&A and discussion
12:25 – 12:30 – The DaRe2THINK trial
Key benefits:
- Continuing Professional Development
- Learn from academic healthcare professionals (HCPs)
- Be informed of relevant published findings
- Engage in discussions with other HCPs
- Exclusive insight into an ongoing national trial
- Find out how to get involved yourself!
Additional Resources
Hosted by
Post
Lipid Therapy State of the Art
This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.
December 16, 2025

